Veriheal

MAY 30, 2023

In this article, we’ll delve into the newest research findings and explore how medicinal cannabis could revolutionize cancer pain management and reduce reliance on opioids and other medications. of the patients reported pain as their primary motivation for obtaining a medicinal cannabis prescription. Interestingly, 72.5%

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

AUGUST 10, 2021

The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?

Data 98

Data Pharmaceutical Treatment Medicine 98

Cannabis Law Report

DECEMBER 8, 2021

Access to headline, upfront, milestone and royalty data. Access to hundreds of Psychiatry deal contract documents. Comprehensive access to over 780 Psychiatry deal records. Access Psychiatry deal headline, upfront, milestone and royalty data. ARCH Personalized Medicine Initiative. Report Scope.

Access 52

Access Data Pharmaceutical Research and Development 52

Cannabis Law Report

AUGUST 24, 2022

Results from the third Cannabis as Medicine study. New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. 25 August 2022.

Medicine 52

Medicine Legalization Chronic Pain Access 52

Cannabis Law Report

AUGUST 23, 2021

Medicinal Cannabis Access Data Dashboard. To improve transparency and data accessibility, the TGA publishes de-identified data on the number of unapproved medicinal cannabis products accessed through the Special Access Scheme (SAS). Here’s what they say. 19 August 2021.

Data 105

Data Access Medicine Patients 105

The Cannigma

NOVEMBER 23, 2021

There is also a lack of access to healthcare professionals, and experts in the field, to guide patients through this complicated process. The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects. Music by Desca. EG: For sure. Let’s listen.

Data 52

Data Patients Access Wellness and Beauty 52

Cannabis Law Report

MAY 10, 2022

More than half of all prescriptions for medicinal cannabis in Australia are written by doctors in Queensland, with prescriptions often given for conditions there is little evidence medicinal cannabis can treat, new research reveals. of prescriptions were for sleep disorders.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Cannabis Law Report

JULY 20, 2021

Rahn & Associates announced today that it launched new risk management solutions for the burgeoning psychedelic medicinal industry. With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”.

Medicine 98

Medicine Business Research and Development Chronic Pain 98

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

NORML

JUNE 10, 2019

Military veterans who participate in a state’s medical marijuana access program frequently report substituting cannabis for alcohol and other controlled substances, according to data published in The American Journal of Drug and Alcohol Abuse. ”

Chronic Pain 264

Chronic Pain Access Collective Medicine 264

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

Cannabis Law Report

JANUARY 23, 2020

Click on image to access THSuite website. Report: Cannabis Users’ Sensitive Data Exposed in Data Breach. Led by internet privacy researchers Noam Rotem and Ran Locar, vpnMentor’s research team discovered a data breach in THSuite, a point-of-sale system in the cannabis industry. THSuite Company Profile.

Data 59

Data Dispensary Patients Medicine 59

Cannabis Law Report

MAY 10, 2022

First comprehensive study reveals why Australians take medicinal cannabis. First academic study of national medicinal cannabis data. The first in-depth study of Australia’s medicinal cannabis program, which began in 2016, shows the drug is being increasingly prescribed for various conditions. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

MAY 14, 2022

The process, which requires non-medicinal CBD products to be the subject of an application for authorisation has caused a stir within UK-CBD stocks and laid bare the industry’s reliance on white-label goods. Medicinal cannabis products have been available since 2018. That position could dramatically change.

Access 52

Access CBD Research and Development Medicine 52

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Sensi Seeds

JANUARY 4, 2019

Context of the Medicinal Cannabis Situation. Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). Under the regulations, no intermediaries are allowed to sell medicinal cannabis to patients.

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

APRIL 1, 2022

Aguilar has suggested that “cannabis must have similar authorization and use conditions” to those that operate in Spain with products such as morphine and has opened the door for, at one time, community pharmacies -and not just hospital ones- dispense cannabinoid-based products that the Medicines Agency may authorize.

Medicine 52

Medicine Data Safety Conditions 52

NORML

JULY 2, 2019

Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs.

Retail 201

Retail Sleep History Medicine 201

Puff Puff Post

DECEMBER 3, 2019

The service breaks down existing barriers for patients by providing convenient access to a broader range of options through a single source, alongside expert advice and counsel from trusted healthcare professionals. Statistics Canada, accessible at [link] n1/daily-quotidien/191030/ t002a-eng.htm. TORONTO, Dec.

Access 52

Access eCommerce Wellness and Beauty Patients 52

NORML

MAY 23, 2019

Seniors who report the use of cannabis over the past year say that it improves their overall quality of life, according to survey data published in the journal Gerontology & Geriatric Medicine. Researchers from the University of Colorado School of Medicine surveyed 274 older respondents (mean age = 72.5

Topical 199

Topical Data Edibles Medicine 199

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Sensi Seeds

DECEMBER 10, 2018

They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. It seems as though research on cannabis and cannabinoids is taking such large strides that it even surpasses research growth in other fields.

Medicine 81

Medicine Research and Development Data Policy 81

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JUNE 23, 2021

According to a recent analysis conducted by cannabis marketing company Digital Third Coast , consumers want even more access, more convenience, and also more restrictions, at least when it comes to advertising cannabis. Digital Third Coast analyzed Google (NASDAQ: GOOG)searches in all fifty states and 34 of the largest U.S.

Data 66

Data Decriminalization Legalization Cannabis 66

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

Clinical Trials 248

Clinical Trials Chronic Pain Cannabinoids Patients 248

Cannabis Law Report

FEBRUARY 5, 2022

Review clinical protocols to ensure the collection of data needed for regulatory submissions. 5+ years’ experience in pharmaceutical industry preferably prescription medicines, narcotics, experimental drugs or products supplied via access schemes. SKILLS/QUALIFICATIONS. Minimum tertiary qualification in relevent field.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Veriheal

APRIL 11, 2024

This data aligns with Americans’ rising acceptance of cannabis. Now, more than 90% of citizens believe that the substance should be legal for medicinal and recreational use, something that would have seemed astonishing even a mere decade ago.

Patients 108

Patients Chronic Pain Marijuana Conditions 108

Cannabis Law Report

DECEMBER 15, 2021

Review clinical protocols to ensure the collection of data needed for regulatory submissions. 5+ years’ experience in pharmaceutical industry preferably prescription medicines, narcotics, experimental drugs or products supplied via access schemes. SKILLS/QUALIFICATIONS. Minimum tertiary qualification in relevent field.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Cannabis Law Report

SEPTEMBER 28, 2021

The TGA has approved the use of MDMA and Psilocybin to treat mental illness in Australia by qualified medical professionals under a special access scheme. My ANIP host organisation (Johnathan Davis MLA’s office) may also use the data. If you withdraw no data from your response will be saved. Participant Information Sheet.

Therapy 52

Therapy Medicine Data Collective 52

NORML

MARCH 7, 2019

Also introduced was The Marijuana Data Collection Act of 2019 , which would study the effects of state legalized medicinal and non-medicinal marijuana programs from a variety of perspectives, including state revenues, public health, substance abuse and opioids, criminal justice, and employment.

Legislation 247

Legislation Marijuana Policy Research and Development 247

The Joint Blog

MAY 5, 2020

PatientsAccording to a new study, access to cannabis reduces pain patients’ perceived demand for opioids. For the study researchers from John Hopkins School of Medicine examined whether or not cannabis availability would hypothetically influence pain patients’ demand for prescription opioids.

Access 49

Access Consumption Marijuana Medicine 49

Puff Puff Post

DECEMBER 3, 2019

The service breaks down existing barriers for patients by providing convenient access to a broader range of options through a single source, alongside expert advice and counsel from trusted healthcare professionals. Statistics Canada, accessible at [link] n1/daily-quotidien/191030/ t002a-eng.htm. TORONTO, Dec.

Access 40

Access eCommerce Wellness and Beauty Patients 40

Healer

NOVEMBER 15, 2023

Let’s start by taking a look at the new data and what it means. First, it’s important to point out that I usually wait until new data makes its way through the scientific peer-review process and is published in a journal before giving it much time and energy. During that time, 2,958 (1.9%) developed heart failure.

Data 126

Data Topical Research and Development Conditions 126

Cannabis Law Report

NOVEMBER 10, 2019

Exclusive data collaboration between The Green Fund and Freshleaf Analytics. In April 2019, QLD amended their patient access process making it easier for doctors to write prescriptions. QLD is also well serviced with a variety of access clinics, which would have contributed to this relative increase. Record growth continues.

Access 45

Access Medicine Data Patients 45

Cannabis Law Report

JULY 13, 2021

The deal with LYPHE Group means that thousands of patients will be the first in Europe to have access to pain relief delivered in a metered dose via Kanabo’s VapePod. Patients can now take their medicine without inhaling soot, tar and carcinogens into the lungs.

Extraction 105

Extraction Vaping Medicine Patients 105

Cannabis Law Report

NOVEMBER 7, 2019

Cannatrek’s Seed to Patient business model combines cutting edge cultivation expertise and world class manufacturing practices to deliver high quality medicinal cannabis oil formulations and medicinal strains of dried flowers at a significantly lower cost to patients and retailers.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40